Aegerion Pharmaceuticals, Inc.
(NASDAQ : AEGR)

( )
AEGR After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
BMYBristol-Myers Squibb Company
-0.82%49.711.4%$1012.77m
PFEPfizer Inc.
-0.61%42.270.9%$1009.17m
JNJJohnson & Johnson
-1.36%128.910.6%$991.20m
MRKMerck & Co., Inc.
-0.03%75.850.6%$985.18m
ABBVAbbVie, Inc.
-0.91%88.692.2%$588.48m
LLYEli Lilly and Company
0.39%117.041.0%$522.86m
AZNAstraZeneca PLC Sponsored ADR
-0.77%36.271.3%$198.52m
NVSNovartis AG Sponsored ADR
-0.78%88.300.2%$161.04m
GSKGlaxoSmithKline plc Sponsored ADR
-0.23%38.970.2%$126.72m
NVONovo Nordisk A/S Sponsored ADR Class B
0.27%48.180.1%$70.93m
SNYSanofi Sponsored ADR
0.02%41.490.2%$38.70m
LCILannett Company, Inc.
2.09%7.8137.0%$11.76m
AKTXAkari Therapeutics Plc Sponsored ADR
-0.58%1.841.7%$0.05m
EPIXESSA Pharma Inc
3.32%4.050.1%$0.03m

Company Profile

Aegerion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development and commercialization of therapies for patients with debilitating rare diseases. The company was founded by David I. Scheer and William H. Lewis on January 5, 2011 and is headquartered in Cambridge, MA.